BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10914317)

  • 1. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).
    Zhang F; McGinity JW
    Drug Dev Ind Pharm; 2000 Sep; 26(9):931-42. PubMed ID: 10914317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion.
    Crowley MM; Schroeder B; Fredersdorf A; Obara S; Talarico M; Kucera S; McGinity JW
    Int J Pharm; 2004 Jan; 269(2):509-22. PubMed ID: 14706261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y; Mehta KA; McGinity JW
    Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
    Ozgüney I; Shuwisitkul D; Bodmeier R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
    Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
    Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
    Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
    Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion.
    Liu J; Zhang F; McGinity JW
    Eur J Pharm Biopharm; 2001 Sep; 52(2):181-90. PubMed ID: 11522484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
    Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
    Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surelease or organic solution of ethylcellulose in preparation of sustained release theophylline micromatrices or matrices using spray drying technique.
    Afrasiabi Garekani H; Sedighi S; Sadeghi F
    Pharm Dev Technol; 2015 Mar; 20(2):204-10. PubMed ID: 24286215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Hydrogenated Soybean Phosphatidylcholine Matrices Prepared by Hot Melt Extrusion for Oral Controlled Delivery of Water-Soluble Drugs.
    Kolbina M; Schulte A; van Hoogevest P; Körber M; Bodmeier R
    AAPS PharmSciTech; 2019 Apr; 20(4):159. PubMed ID: 30968304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of methylparaben as a solid-state plasticizer on the physicochemical properties of Eudragit RS PO hot-melt extrudates.
    Wu C; McGinity JW
    Eur J Pharm Biopharm; 2003 Jul; 56(1):95-100. PubMed ID: 12837487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.